ANIP Earnings & Financial Statements
ANI Pharmaceuticals, Inc.
$72.60
+$2.44(+3.47%)
52
Overall
75
Value
30
Tech
52
Quality
Market Cap
$1.61B
Volume
77.71K
52W Range
$69.58 - $97.00
Target Price
$102.80
ANIP earnings and financial statements: ANI Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ANIP Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $883.37M | $614.38M | $486.82M | - | - |
| Cost of revenue | $341.31M | $317.94M | $241.30M | - | - |
| Operating income | $80.85M | -$10.60M | $49.37M | - | - |
| EBITDA | $207.27M | $74.09M | $110.55M | - | - |
| Net income | $78.34M | -$28.53M | $23.82M | - | - |
| EPS (diluted) | $3.32 | $-1.04 | $0.85 | $-3.05 | $-3.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANIP | $72.60 | +3.5% | 77.71K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get ANI Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW